Annotation Detail for LDHD

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa00620 | Pyruvate metabolism |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of LDHD protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of LDHD mRNA | decreases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of LDHD mRNA | decreases expression | 20106945
|
D015741 |
Metribolone |
Metribolone results in increased expression of LDHD protein | increases expression | 17152098
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of LDHD mRNA | decreases expression | 12832660
|
D014112 |
Toxaphene |
Toxaphene results in decreased expression of LDHD protein | decreases expression | 1269500
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.82 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Toxaphene |
5.71 | 16132792 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.49 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 20146248 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.98 | 12619106 12907637 21507988 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.12 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.73 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.53 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.53 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.66 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.66 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.56 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.80 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 16221962 19772884 19176532 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.50 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.00 | 12371664 |
MESH:D007945 |
Leukemia, Lymphoid |
|
Toxaphene |
6.75 | 16132792 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.98 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.98 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.98 | 20007298 15890375 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.92 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.49 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.49 | 18816296 18520028 20869020 20064080 18569708 6695378 20464547 20135361 17053015 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.43 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
9.25 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
9.25 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Toxaphene |
9.25 | 8820588 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 19348381 18481113 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
MESH:D011248 |
Pregnancy Complications |
|
Toxaphene |
6.27 | 2087686 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.92 | 17292933 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.49 | 10029692 19755658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.28 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |
Pathway ID |
Pathway Name |
---|
KEGG:00620 |
Pyruvate metabolism |